$XBI $90.68 | -3.07%
Covid Updates
$CYDY +0.8% CytoDyn Announces Partial Clinical Hold of HIV Program and Full Clinical Hold of COVID-19 Program source
Pipeline Updates
$ELOX +10.0% Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome source
$PTCT -4.0% PTC Therapeutics Announces Initiation of PIVOT-HD Phase 2 Clinical Trial to Evaluate PTC518 in Patients with Huntington's Disease source
$AKBA -66.0% Akebia Therapeutics Receives Complete Response Letter from the FDA for Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients source
$ANIX +1.3% Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center source
$ACIU -6.5% AC Immune KOL Webinar on First Clinical Proof of Concept for Alpha-synuclein Diagnostic Shows Breakthrough Potential for Neurodegenerative diseases. source
$GRAY -3.1% Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023. source
$REPL +2.0% Replimune Provides New Clinical Data, Broad Program Update and Future Development Strategy for its Tumor-Directed Oncolytic Immunotherapies. source
$DSGN -2.9% Design Therapeutics Completes Dosing in First Patient Cohort of Phase 1 Trial of DT-216 GeneTAC™ Molecule for the Treatment of Friedreich Ataxia. source
Business Updates
$COLL -1.1% Collegium Announces Master Settlement Agreement Resolving Pending Opioid-Related Litigation. source
Posted by FS/JM
Comments